These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine. Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568 [TBL] [Abstract][Full Text] [Related]
3. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH. Coyne GO; Takebe N; Chen AP Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823 [TBL] [Abstract][Full Text] [Related]
4. An overview of the NCI precision medicine trials-NCI MATCH and MPACT. Do K; O'Sullivan Coyne G; Chen AP Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298 [TBL] [Abstract][Full Text] [Related]
5. Lung cancer as a paradigm for precision oncology in solid tumours. Schallenberg S; Merkelbach-Bruse S; Buettner R Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537 [TBL] [Abstract][Full Text] [Related]
6. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725 [TBL] [Abstract][Full Text] [Related]
7. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine. Damodaran S; Berger MF; Roychowdhury S Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170 [TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing in Oncology in the Era of Precision Medicine. Blumenthal GM; Mansfield E; Pazdur R JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172 [No Abstract] [Full Text] [Related]
9. Perspective on Precision Medicine in Oncology. Johnson TM Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968 [TBL] [Abstract][Full Text] [Related]
10. Targeted therapy: a potential oversight in trial protocol. Moorthy T Lancet Oncol; 2018 Sep; 19(9):e439. PubMed ID: 30191846 [No Abstract] [Full Text] [Related]
11. Pediatric oncology enters an era of precision medicine. Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740 [TBL] [Abstract][Full Text] [Related]
12. Precision medicine: In need of guidance and surveillance. Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702 [TBL] [Abstract][Full Text] [Related]
13. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience. Lih CJ; Takebe N Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332 [TBL] [Abstract][Full Text] [Related]
14. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review. Syn NL; Yong WP; Goh BC; Lee SC Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175 [TBL] [Abstract][Full Text] [Related]
15. Translating genomics for precision cancer medicine. Roychowdhury S; Chinnaiyan AM Annu Rev Genomics Hum Genet; 2014; 15():395-415. PubMed ID: 25184532 [TBL] [Abstract][Full Text] [Related]
16. Universal Genomic Testing: The next step in oncological decision-making or a dead end street? Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701 [TBL] [Abstract][Full Text] [Related]
17. Genomic medicine and risk prediction across the disease spectrum. Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499 [TBL] [Abstract][Full Text] [Related]
18. Cancer genomics guide clinical practice in personalized medicine. Lehmann-Che J; Poirot B; Boyer JC; Evrard A Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721 [TBL] [Abstract][Full Text] [Related]
19. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies. Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741 [TBL] [Abstract][Full Text] [Related]